• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测和评估早发性肾癌患者预后的新型列线图:一项基于人群的研究。

A Novel Nomogram for the Prediction and Evaluation of Prognosis in Patients with Early-onset Kidney Cancer: a Population-based Study.

作者信息

Lv Dingyang, Wang Qiwei, Sun Ke, Li Jinshuai, Zhou Huiyu, Wen Jie, Shuang Weibing

机构信息

Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.

First Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi Province, China.

出版信息

J Cancer. 2025 Jan 13;16(4):1189-1201. doi: 10.7150/jca.104569. eCollection 2025.

DOI:10.7150/jca.104569
PMID:39895778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11786041/
Abstract

Early-onset kidney cancer (EOKC) is often associated with genetic factors and a high risk of metastasis. However, there is a lack of accurate prediction models for the prognosis of EOKC. The aim of this study is to establish an effective nomogram for predicting and evaluating the prognosis of patients with EOKC. The patients with EOKC were selected from the latest SEER database during 2004-2015. Patients between 2004 and 2014 were randomly divided into a training cohort and a validation cohort at a ratio of 7:3, and patients in 2015 were used for temporal external validation. Additionally, we included patients from First Hospital of Shanxi Medical University between 2013 and 2021 for spatial external validation. The performance of the nomogram was assessed using the concordance index (C-index), receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Patients were stratified based on the nomogram, and Kaplan-Meier (KM) curves were plotted to compare the survival probability of patients. In the temporal and spatial external validation cohort, the C-index of the nomogram for OS was 0.872 and 0.875, respectively, and the C-index of the nomogram for CSS were 0.872 and 0.851, respectively. In the temporal external validation cohort, the 1-year, 3-year and 5-year AUC of the nomogram for OS were 0.906, 0.899 and 0.876, respectively. In addition, the AUC showed that the nomogram had also high predictive ability for CSS. The calibration curves and DCA also indicated that the nomogram had a strong clinical utility. The KM curve revealed that patients in the low-risk group had a better prognosis than those in the high-risk group. Our study developed a novel high-performance nomogram for assessing the prognosis of patients with EOKC, and it has great potential for clinicians to assess patient prognosis and formulate effective intervention and follow-up strategies.

摘要

早发性肾癌(EOKC)通常与遗传因素及高转移风险相关。然而,目前缺乏针对EOKC预后的准确预测模型。本研究旨在建立一种有效的列线图,用于预测和评估EOKC患者的预后。EOKC患者选自2004 - 2015年最新的SEER数据库。2004年至2014年的患者按7:3的比例随机分为训练队列和验证队列,2015年的患者用于时间外部验证。此外,我们纳入了山西医科大学第一医院2013年至2021年的患者进行空间外部验证。使用一致性指数(C指数)、受试者工作特征(ROC)曲线、校准曲线和决策曲线分析(DCA)评估列线图的性能。根据列线图对患者进行分层,并绘制Kaplan-Meier(KM)曲线以比较患者的生存概率。在时间和空间外部验证队列中,总生存期(OS)列线图的C指数分别为0.872和0.875,癌症特异性生存期(CSS)列线图的C指数分别为0.872和0.851。在时间外部验证队列中,OS列线图的1年、3年和5年曲线下面积(AUC)分别为0.906、0.899和0.876。此外,AUC表明列线图对CSS也具有较高的预测能力。校准曲线和DCA也表明列线图具有较强的临床实用性。KM曲线显示,低风险组患者的预后优于高风险组患者。我们的研究开发了一种用于评估EOKC患者预后的新型高性能列线图,对临床医生评估患者预后及制定有效的干预和随访策略具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/8ca526488f8c/jcav16p1189g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/b48a38fd4b3c/jcav16p1189g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/51609fa6f6df/jcav16p1189g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/9d2d4437fee7/jcav16p1189g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/58221eaa2a08/jcav16p1189g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/55cbf1085528/jcav16p1189g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/261ba31e4707/jcav16p1189g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/727e548f0719/jcav16p1189g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/8ca526488f8c/jcav16p1189g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/b48a38fd4b3c/jcav16p1189g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/51609fa6f6df/jcav16p1189g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/9d2d4437fee7/jcav16p1189g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/58221eaa2a08/jcav16p1189g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/55cbf1085528/jcav16p1189g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/261ba31e4707/jcav16p1189g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/727e548f0719/jcav16p1189g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1338/11786041/8ca526488f8c/jcav16p1189g008.jpg

相似文献

1
A Novel Nomogram for the Prediction and Evaluation of Prognosis in Patients with Early-onset Kidney Cancer: a Population-based Study.一种用于预测和评估早发性肾癌患者预后的新型列线图:一项基于人群的研究。
J Cancer. 2025 Jan 13;16(4):1189-1201. doi: 10.7150/jca.104569. eCollection 2025.
2
Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer.青年肾癌患者预后列线图的开发与验证
Int J Gen Med. 2021 Sep 1;14:5091-5103. doi: 10.2147/IJGM.S331627. eCollection 2021.
3
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.
4
The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.基于 SEER 数据库和中国队列研究的列线图预测胰腺癌患者放疗后总生存的研究。
Front Endocrinol (Lausanne). 2023 Oct 25;14:1266318. doi: 10.3389/fendo.2023.1266318. eCollection 2023.
5
Development of a Nomogram-Based Online Calculator for Predicting Cancer-Specific Survival in Patients With Digestive Tract Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms (MiNENs): An Analysis of the SEER Database.基于列线图的在线计算器的开发,用于预测消化道混合性神经内分泌-非神经内分泌肿瘤(MiNENs)患者的癌症特异性生存率:监测、流行病学和最终结果(SEER)数据库分析
Cancer Rep (Hoboken). 2025 Feb;8(2):e70156. doi: 10.1002/cnr2.70156.
6
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.预测原发性腮腺鳞状细胞癌患者术后总体生存率和癌症特异性生存率的列线图:一项基于人群的研究。
Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8.
7
Prognostic nomogram for primary splenic lymphoma: a SEER database-based study.原发性脾淋巴瘤的预后列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Am J Cancer Res. 2023 Dec 15;13(12):5825-5845. eCollection 2023.
8
Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.基于监测、流行病学和最终结果(SEER)数据库及外部验证队列的转移性非小细胞肺癌动态生存列线图的开发与验证
Transl Lung Cancer Res. 2022 Aug;11(8):1678-1691. doi: 10.21037/tlcr-22-544.
9
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.基于 SEER 数据库的老年早期肝细胞癌患者癌症特异性生存的网络预测模型研究。
Front Public Health. 2022 Jan 13;9:789026. doi: 10.3389/fpubh.2021.789026. eCollection 2021.
10
Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.基于 SEER 人群的研究:预测局部晚期乳腺癌患者总生存和癌症特异性生存的列线图的建立和验证。
Front Public Health. 2022 Sep 20;10:969030. doi: 10.3389/fpubh.2022.969030. eCollection 2022.

本文引用的文献

1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8 T-cells highly infiltrated in males.肾细胞癌的性别差异:单细胞分析揭示男性中高度浸润的耗尽 CD8 T 细胞。
Biol Sex Differ. 2023 Sep 15;14(1):58. doi: 10.1186/s13293-023-00540-9.
3
Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.肾细胞癌患者生存结局种族差异的社会经济决定因素。
Urol Oncol. 2023 Nov;41(11):460.e1-460.e9. doi: 10.1016/j.urolonc.2023.08.016. Epub 2023 Sep 14.
4
Preoperative serum low-density lipoprotein cholesterol is an independent prognostic factor in patients with renal cell carcinoma after nephrectomy.术前血清低密度脂蛋白胆固醇是肾细胞癌患者肾切除术后的独立预后因素。
Lipids Health Dis. 2023 Feb 22;22(1):26. doi: 10.1186/s12944-023-01791-6.
5
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
6
Prognosis of clear cell renal cell carcinoma patients stratified by age: A research relied on SEER database.按年龄分层的透明细胞肾细胞癌患者的预后:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2022 Oct 12;12:975779. doi: 10.3389/fonc.2022.975779. eCollection 2022.
7
A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.一种基于人群的研究:预测肾细胞癌患者肾切除术后总生存的新型列线图和风险分类系统。
Front Public Health. 2022 Oct 5;10:989566. doi: 10.3389/fpubh.2022.989566. eCollection 2022.
8
Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.转移性透明细胞肾细胞癌患者癌症特异性生存预测列线图的开发与验证:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2022 Sep 28;12:949058. doi: 10.3389/fonc.2022.949058. eCollection 2022.
9
Epidemiology of Renal Cell Carcinoma: 2022 Update.肾细胞癌的流行病学:2022 年更新。
Eur Urol. 2022 Nov;82(5):529-542. doi: 10.1016/j.eururo.2022.08.019. Epub 2022 Sep 10.
10
A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study.基于网络的老年早期肾细胞癌患者总生存预测模型:基于人群的研究。
J Transl Med. 2022 Feb 14;20(1):90. doi: 10.1186/s12967-022-03287-w.